SCHEMBL22189174

SCHEMBL22189174

c1ccc2c(c1)oc1cccc(Nc3cccc4c5ccccc5c5ccccc5c34)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
MAPT P10636 6/20 0.42
HPGD P15428 5/20 0.42
KDM4E B2RXH2 4/20 0.42
MAOA P21397 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
GLA P06280 3/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP3A4 P08684 1/20 0.42
PGAM1 P18669 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
LMNA P02545 2/20 0.41
CDC14B O60729 1/20 0.39
CDC14A Q9UNH5 1/20 0.39
EPHX2 P34913 1/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
TDP1 Q9NUW8 2/20 0.36
GAA P10253 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20181893 0.92 MAPT (0.45) ALDH1A1MAPTHPGDKDM4EMAOA
SCHEMBL17380890 0.87 AHR (0.45) ALDH1A1MAPTHPGDKDM4EMAOA
SCHEMBL15790419 0.85 EPHX2 (0.53) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL29450789 0.85 EPHX2 (0.53) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17381080 0.84 AHR (0.39) ALDH1A1MAPTHPGDKDM4EMAOA
SCHEMBL20181980 0.84 GAA (0.55) ALDH1A1MAPTHPGDKDM4EMAOA
SCHEMBL29177959 0.84 MAOA (0.41) ALDH1A1MAPTHPGDKDM4EMAOA
SCHEMBL20832518 0.84 ALDH1A1 (0.42) ALDH1A1MAPTHPGDKDM4EMAOA
SCHEMBL28495469 0.84 ALDH1A1 (0.60) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL6540408 0.83 GAA (0.48) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12590249-B2 Etchant composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-03-31 US claimed
US-20220025261-A1 ETCHANT COMPOSITION SOULBRAIN CO., LTD. (KR) 2022-01-27 US claimed
US-12590249-B2 Etchant composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-03-31 US disclosed
US-20220025261-A1 ETCHANT COMPOSITION SOULBRAIN CO., LTD. (KR) 2022-01-27 US disclosed
US-11142694-B2 Etchant composition and method of fabricating semiconductor device SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20200216758-A1 ETCHANT COMPOSITION AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE SOULBRAIN CO., LTD. (KR) 2020-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590249-B2 Etchant composition ASIC1, NOS1, CA1 ALDH1A1 2289/4885MAPT 4205/4885HPGD 3746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.